New England Journal of Medicine

Trending/New England Journal of Medicine

Masked staff member shows literature to masked cancer patient receiving treatment

Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

ROCHESTER, Minn. — A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy…

Sign up